Enovis Corp

Enovis Corp

Health CareMedical Equipment and Services
  • Price (USD)56.24
  • Today's Change2.45 / 4.55%
  • Shares traded309.55k
  • 1 Year change-16.58%
  • Beta1.8695
Data delayed at least 15 minutes, as of Jun 02 2023 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Enovis Corporation is a medical technology company. The Company is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity solutions that serve the orthopedic reconstructive joint implant market.

  • Revenue in USD (TTM)1.59bn
  • Net income in USD-23.47m
  • Incorporated1998
  • Employees6.80k
  • Location
    Enovis Corp2711 CENTERVILLE ROAD, SUITE 400WILMINGTON 19808United StatesUSA
  • Phone+1 (302) 252-9160
  • Fax+1 (301) 323-9001
  • Websitehttps://www.enovis.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ENOV:NYQ since
Novastep SASAnnounced03 Apr 202303 Apr 2023Announced5.14%--
Orthopy Health GmbHAnnounced01 Mar 202301 Mar 2023Announced-2.40%--
Data delayed at least 15 minutes, as of Jun 02 2023 21:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Titan Machinery Inc2.32bn110.21m631.66m2.70k5.671.124.570.27254.924.92103.4424.891.942.7421.45858,492.609.324.7416.988.5920.2619.204.802.700.286938.360.49090.0029.0613.1254.56--7.34--
Douglas Dynamics Inc596.01m29.41m689.06m1.81k23.343.1813.641.161.281.2826.039.431.052.7413.06328,743.505.182.366.212.7023.7727.274.932.740.54034.010.5414174.9513.785.3425.80-12.919.763.86
Astec Industries, Inc.1.33bn7.90m949.07m4.29k120.111.4927.190.71290.34780.347858.3928.011.362.708.59310,230.700.75830.39811.040.514221.5719.710.55590.30270.95711.460.1068280.1516.161.47-100.56--15.224.14
Lindsay Corp746.86m79.58m1.37bn1.26k17.323.2513.791.847.207.1767.5638.361.082.854.92591,802.7011.496.1214.587.5330.2727.3410.666.142.2742.050.214739.9335.788.2753.3023.2011.962.60
Alamo Group, Inc.1.56bn116.81m2.14bn4.20k18.262.5913.071.379.789.78130.8868.861.133.234.73372,233.808.447.139.888.3425.7424.997.476.082.3610.160.3118.5913.4510.6527.0213.3218.3412.47
Enovis Corp1.59bn-23.47m3.06bn6.80k--0.8916.781.92-0.4469-0.96329.3663.190.24941.073.40234,381.60-0.35950.1305-0.42020.152956.4743.89-1.440.39841.13--0.07640.009.60-4.2062.48--8.93--
ESAB Corp2.63bn200.94m3.80bn9.00k18.912.6813.671.443.343.3043.6423.570.68923.786.46292,174.305.42--6.60--34.55--7.86--0.97136.470.4549--6.81---4.21------
AGCO Corporation13.30bn970.40m8.94bn25.60k9.222.167.650.672112.9512.95177.5055.221.292.9210.08519,500.008.715.5113.588.9024.2522.626.774.520.6742110.930.324634.9213.588.78-0.82531.2513.7510.44
Lincoln Electric Holdings Inc3.88bn468.13m10.47bn12.00k22.749.3019.112.708.008.0066.1919.551.294.067.11322,925.5015.6312.3622.1616.4733.8133.5512.089.791.1313.980.507639.2616.307.4670.8111.343.129.86
Toro Co4.73bn480.69m10.64bn11.29k22.407.3717.952.254.564.5644.8313.851.373.1912.73419,141.7013.9214.4119.4921.1133.8234.2010.1610.000.633914.560.430429.9314.0212.508.1610.6120.9311.38
Data as of Jun 02 2023. Currency figures normalised to Enovis Corp's reporting currency: US Dollar USD

Institutional shareholders

53.79%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Investment Management, Inc.as of 31 Mar 20236.57m12.09%
The Vanguard Group, Inc.as of 31 Mar 20234.81m8.85%
BlackRock Fund Advisorsas of 31 Mar 20234.35m8.00%
Dimensional Fund Advisors LPas of 31 Mar 20232.90m5.34%
Durable Capital Partners LPas of 31 Mar 20232.71m5.00%
Diamond Hill Capital Management, Inc.as of 31 Mar 20232.16m3.98%
Thrivent Asset Management LLCas of 31 Mar 20231.56m2.87%
SSgA Funds Management, Inc.as of 31 Mar 20231.47m2.71%
Channing Capital Management LLCas of 31 Mar 20231.39m2.55%
Select Equity Group LPas of 31 Mar 20231.30m2.40%
More ▼
Data from 31 Mar 2023 - 31 Mar 2023Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.